Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study-Reference-Cited by-同舟云学术

Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study

Published:2001-09 Issue:13 Volume:37 Page:1624-1628
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Wagenaar H.C.,Pecorelli S.,Mangioni C.,van der Burg M.E.L.,Rotmensz N.,Anastasopoulou A.,Zola P.,Veenhof C.H.N.,Lacave A.J.,Neijt J.P.,van Oosterom A.T.,Einhorn N.,Vermorken J.B.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Cisplatin in advanced cancer of the cervix;Alberts;Semin. Oncol.,1991

2. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix;Alberts;J. Clin. Oncol.,1987

3. The role of chemotherapy in squamous cell carcinoma of the uterine cervix;Vermorken;Int. J. Gynecol. Cancer,1993

4. Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix;Vermorken;Int. J. Gynecol. Cancer,2000

5. Reporting results of cancer treatment;Miller;Cancer,1981

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement;Gynecologic Oncology;2023-12

2. Management of Recurrent Uterine Cervical Cancer;Uterine Cervical Cancer;2019

3. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review;Critical Reviews in Oncology/Hematology;2016-12

4. Treatment of Inoperable Vulvar Cancer: Where We Come From and Where Are We Going;International Journal of Gynecologic Cancer;2016-11

5. Developments in the systemic treatment of metastatic cervical cancer;Cancer Treatment Reviews;2013-08